HIWU Issues Horsemen’s Advisory Regarding Adenosine and Hemo 15

[Wandering Eyes]

In recent months, the Horseracing Integrity & Welfare Unit (HIWU) has adjudicated several cases under the Anti-Doping and Medication Control (ADMC) Program related to adenosine, a vasodilator, and Hemo 15, a foreign product that lacks FDA approval, according to an advisory from HIWU, which says that neither substance has any valid veterinary use in the racehorse.

“Both substances are categorized as an S0 Non-Approved Banned Substance and therefore are prohibited from Use in a Covered Horse or Possession by a Covered Person at all times,” reads the advisory. “Hemo 15 and any compounded product mimicking Hemo 15, as well as any products containing adenosine, adenosine monophosphate (AMP), or adenosine triphosphate (ATP) should be disposed of immediately.”

The advisory goes on to remind horsemen that “the Presence, Use, Administration, Possession, or Trafficking of any Banned Substance is subject to a period of Ineligibility of up to two years, a fine of up to $25,000, the disqualification of race results (as applicable), and public disclosure.”

Horsemen or veterinarians with questions are advised to reach out to sciencesupport@hiwu.org.

The post HIWU Issues Horsemen’s Advisory Regarding Adenosine and Hemo 15 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

View the full article